The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

VISCHER

AESCHENVORSTADT 4, 4010 BASEL, SWITZERLAND
Tel:
Work +41 58 211 33 00
Fax:
Fax +41 58 211 33 10
Email:
Web:
www.vischer.com
Basel, ZURICH

Christian Wyss

Tel:
Work +41 58 211 33 39
Email:
VISCHER

Work Department

Life Sciences, Corporate & Commercial, IP/IT

Position

Christian Wyss is Partner and head of VISCHER's Corporate & Commerial team. Christian advises clients mainly from the Life Sciences and Information Technology industries on all contractual requirements in their core business. He has extensive experience in drafting and negotiating license agreements, research, development or marketing co-operations, clinical trial agreements, contract manufacturing agreements and distribution agreements. Christian also regularly works with clients in financing rounds, acquisitions, or joint ventures, and assists with implementing compliance with the Swiss data protection laws.

Career

Christian was admitted to the bar in Switzerland in 2002. He joined VISCHER as an Associate in 2005 and has been elected Partner in 2015. Before joining VISCHER, he worked as a law clerk at the Basel-Land Criminal Court and as a legal intern with a corporate law firm in Basel and the Basel-Land Criminal Court.

Languages

German, English, French.

Member

Licensing Executives Society International, International Bar Association, Swiss Bar Association, Basel Bar Association, Pro Iure

Education

University of Lausanne (1998/1999), University of Basel (lic. iur., 2000), Wake Forest University School of Law (LL.M., 2005)


Switzerland

Healthcare and life sciences

Within: Next generation lawyers

Christian Wyss - VISCHER

Within: Healthcare and life sciences

VISCHER is renowned for its expertise in corporate, commercial, transactional, regulatory and patent-related healthcare and biotech matters. Matthias Staehelin assisted Medartis with its initial public offering on the SIX Swiss Exchange, while Stefan Kohler acted for Novo Nordisk Pharma in its appeal against a pricing decision made by the Swiss Federal Office of Public Health concerning the client's type-two diabetes product. Christian Wyss advised Lundbeck on its €905m acquisition of Prexton Therapeutics.

[back to top]

Intellectual property

Within: Intellectual property

The intellectual property department at VISCHER covers protective, strategic, transactional and contentious matters in relation to patents, copyright, designs and trade marks. Christian Wyss assisted Balderton Capital with the IP due diligence in preparation for its investment into Sophia Genetics' $30m financing round, while team lead Stefan Kohler advises Philipp Morris on the agreements required for the technological development of reduced-risk tobacco products. Rolf Der Maur, who combines intellectual property law with IT expertise, is another name to note.

[back to top]

Leading firms: German-speaking Switzerland

Within: Leading firms: German-speaking Switzerland

VISCHER has core strength in the healthcare, TMT and transport sectors and notable public law expertise, while also fielding strong capital markets, M&A, competition and litigation departments. Key partners include Stefan Kohler, Rolf Auf der Maur, Stefan Rechsteiner, Benedict Christ  and Christian Oetiker. Michael Waldner and Christian Wyss are other names to note.

[back to top]

TMT

Within: TMT

VISCHER's TMT practice has experience of sector-relevant convergence issues, regulatory requirements, online services licensing, outsourcing and transfer agreements. Rolf Auf der Maur successfully represented Swisscom as defendant in the first Swiss ISP-blocking matter brought by film rights holders, while Basel-based Christian Wyss assists Sympany with the review, drafting and negotiation of various different IT agreements with suppliers and outsourcing providers. Netflix, Quadrant and Additiv also feature in the client list.

[back to top]


Back to index

Legal Developments by:
VISCHER

  • Capital Contribution Principle: Meaning and Proceedings

    On January 1, 2011, the Swiss tax law capital contribution principle (CCP) enters into force - with far reaching consequences for companies, their owners, board members and tax advisors. A few days ago the Federal Tax Administration (FTA) published a Circular Letter on this change of law.
    - VISCHER

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to